Research from 2021 shows that online trauma therapy can be as effective as in-person therapy. The review found that live ...

Evernorth — the Cigna division that oversees the Express Scripts pharmacy benefit manager business — has added an option ... copays for two popular weight-loss drugs, Wegovy and Zepbound, at $200.

The Cigna Group (NYSE:CI)’s Evernorth division ... out-of-pocket expenses for weight-loss drugs Zepbound and Wegovy to $200. Beginning in the second half of 2025, the program targets businesses ...

The Cigna Group (NYSE:CI)'s Evernorth division has ... of-pocket expenses for weight-loss drugs Zepbound and Wegovy to $200. A healthcare team discussing strategies for patient advocacy programs.

The Cigna Group (NYSE:CI)'s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit insured customers' monthly out-of-pocket expenses for weight-loss drugs Zepbound ...

These plans come with flexible options ... more. Cigna’s Part D prescription drug plans are ideal for those with prescriptions that require consistent upkeep. These plans feature low copays ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Cigna’s Evernorth has reached new deals with ...

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...

Cigna has announced a new benefit that caps patient out-of-pocket costs at $200 per month for the weight-loss drugs Wegovy (by Novo Nordisk) and Zepbound (by Eli Lilly). This initiative ...

For those who have been hesitant to cover the medications because of cost, capping employee out-of-pocket costs at $200 would amount ... access Zepbound." While Cigna would not discuss the actual ...